Journal Information

Statistics

Follow this link to access the full text of the article

Original Article
A cost-consequence analysis of the preferential use of secukinumab versus adalimumab for the treatment of psoriatic arthritis
Análisis de las consecuencias en materia de costos del uso preferencial del secukinumab en comparación con el adalimumab para el tratamiento de la artritis psoriásica
Alberto Jiménez-Moralesa, Rafael Cáliza, Susana Aceitunob, Miriam Pradesb, Carles Blanchc,
Corresponding author
carles.blanch@novartis.com

Corresponding author.
a Virgen de las Nieves University Hospital, Granada, Spain
b Outcomes’10, Castellón de la Plana, Spain
c Novartis Pharmaceuticals, Novartis Farmacéutica, Barcelona, Spain
Read
5395
Times
was read the article
3544
Total PDF
1851
Total HTML
Share statistics
Article information
ISSN: 21735743
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 7 0 7 7
2025 6 3 15 18
2025 5 78 52 130
2025 4 75 23 98
2025 3 55 31 86
2025 2 52 47 99
2025 1 54 48 102
2024 12 43 47 90
2024 11 32 39 71
2024 10 31 35 66
2024 9 34 30 64
2024 8 53 58 111
2024 7 42 45 87
2024 6 30 30 60
2024 5 42 31 73
2024 4 35 37 72
2024 3 30 29 59
2024 2 21 30 51
2024 1 23 30 53
2023 12 34 27 61
2023 11 57 67 124
2023 10 46 41 87
2023 9 142 55 197
2023 8 153 22 175
2023 7 27 2184 2211
2023 6 27 34 61
2023 5 29 35 64
2023 4 16 22 38
2023 3 48 25 73
2023 2 40 25 65
2023 1 24 15 39
2022 12 61 37 98
2022 11 61 36 97
2022 10 85 33 118
2022 9 65 40 105
2022 8 66 40 106
2022 7 46 45 91
2022 6 44 40 84
2022 5 47 55 102
2022 2 0 2 2
Show all

Follow this link to access the full text of the article

Idiomas
Reumatología Clínica (English Edition)
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?